Core Viewpoint - Fortrea Holdings Inc. reported quarterly earnings of 0.36 per share, representing a 50% earnings surprise [1] - The company has consistently failed to surpass consensus EPS estimates over the last four quarters [2] Financial Performance - Fortrea Holdings Inc. posted revenues of 775.4 million year-over-year [2] - The company has only topped consensus revenue estimates once in the last four quarters [2] Stock Performance - Fortrea Holdings Inc. shares have declined approximately 25.7% since the beginning of the year, while the S&P 500 has gained 1.2% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating expected underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is 659.7 million, and for the current fiscal year, it is 2.72 billion [7] - The trend of estimate revisions for Fortrea Holdings Inc. has been unfavorable leading up to the earnings release [6] Industry Context - The Medical - Biomedical and Genetics industry, to which Fortrea Holdings Inc. belongs, is currently in the top 28% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - Research indicates that the top 50% of Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1 [8]
Fortrea Holdings Inc. (FTRE) Q4 Earnings and Revenues Miss Estimates